Position in ZVRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,704,292
-$1,136,619 QoQ
Shares Held
182,864
-42.3% QoQ
Ownership
0.309%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
13 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Derivatives in ZVRA
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$1,318,240
PutShares
176,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $1,094,861,392 across 233 Biotechnology names. ZVRA ranks #81 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
426,723 | $141,189,839 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
162,814 | $125,796,608 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,349,516 | $64,736,282 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
695,276 | $52,208,274 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
556,324 | $41,312,620 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
52,884 | $27,683,187 | |
| 7 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,103,490 | $25,998,224 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,705,829 | $24,666,287 |
All Filings in ZVRA
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,704,292 | 182,864 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,840,911 | 317,066 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,549,412 | 268,077 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $509,694 | 68,050 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $1,318,240 | 176,000 | Put | Defined | 2025-08-27 | |
| 2024-12-31 | $137,893 | 16,534 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $84,321 | 12,150 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $129,525 | 22,332 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $151,357 | 23,108 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $92,437 | 19,178 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $95,426 | 18,711 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $111,413 | 20,257 | Shares | Defined | 2023-05-15 | |
| 2021-12-31 | $88,859 | 10,202 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $241,095 | 26,206 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||